Lehrstuhl für Innere Medizin V

Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome (2016) Voelkl S, Rensing-Ehl A, Allgäuer A, Schreiner E, Lorenz MR, Rohr J, Klemann C, et al. Journal article Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism (2015) Leisz S, Schulz K, Erb S, Oefner P, Dettmer K, Mougiakakos D, Wang E, et al. Journal article Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects (2015) Meinhardt K, Kroeger I, Bauer R, Ganss F, Ovsiy I, Rothamer J, Büttner M, et al. Journal article NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation (2015) Jacobs B, Tognarelli S, Poller K, Bader P, Mackensen A, Evelyn U Journal article Adverse airway events in parturient compared with non-parturient patients. Is there a difference? Results from a quality management project (2015) Heinrich S, Irouschek A, Prottengeier J, Ackermann A, Schmidt J Journal article Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma (2015) Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann M, Beier F, et al. Journal article Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation (2015) Von Bahr L, Blennow O, Alm J, Bjorklund A, Malmberg KJ, Mougiakakos D, Le Blanc A, et al. Journal article Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling (2015) Jitschin R, Braun M, Qorraj M, Saul D, Le Blanc K, Zenz T, Mougiakakos D Journal article What opportunities does Immuno-oncology indicate for overarching long-term survival? (2015) Bergmann L, Brugger W, Herr W, Mackensen A, Multhoff G Journal article Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial (2015) Rollig C, Serve H, Huettmann A, Noppeney R, Mueller-Tidow C, Krug U, Baldus CD, et al. Journal article